Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New appointment at iPierian

This article was originally published in Scrip

Executive Summary

iPierian, a California-based biopharmaceutical firm, has appointed Dr Michael Venuti as president and chief scientific officer. Dr Venuti has 25 years of experience and is charged with establishing large-scale discovery and development collaborations to help iPierian advance its neurodegenerative programmes and partnerships in metabolic disease. Dr Venuti was previously CEO of BioSeek, which was acquired by Asterand earlier this month.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts